. Neurological complications of pertussis inoculation. Findings are presented in 36 children, seen in the past 11 years, who are believed to have suffered from neurological complications of pertussis inoculation (given as triple vaccine). The clustering of complications in the first 24 hours after inoculation suggests a causal rather than a coincidental relation. Possible contributory factors were present in one-third of patients studied and support the view that idiosyncratic features are present in the patients, not the vaccine. A prospective review is urged. It is recommended that pertussis vaccine should not be given to patients with a history of fits, or a family history of fits in first-degree relatives, or to those who have had a reaction to previous inoculations, those who have had recent intercurrent infection, or those with presumed neurological deficit.
Inoculation against pertussis has been for several decades an accepted prophylactic procedure to reduce mortality and morbidity of this infectious disease, especially in very young children. Several papers have considered what is the optimum immunization schedule which would (a) protect the child at an age when most at risk from complications, (b) offer immunization at an age when an adequate immune response can be achieved, and (c) achieve a satisfactory level of 'herd' immunity (Sako et al., 1945; Miller, 1951; Vahlquist, Hesselvik, and Ericsson, 1954; Provenzano, Wetterlow, and Ipsen, 1959;  Goddard, 1964; Ehrengut, 1966) .
There have been, too, reports about neurological complications after pertussis immunization. The first, about two fatal cases, came from Denmark (Madsen, 1933) and was soon followed by observations in other countries (Globus and Kohn, 1949; Byers and Moll, 1948; Sutherland, 1953; Miller and Stanton, 1954) .
The severe neurological complications orginally seen after pertussis inoculation and after the administration of the combined vaccines that are widely used (mainly combined diphtheria, pertussis, and tetanus vaccine-DPT) are identical (Miller and Stanton, 1954; Berg, 1958; Hopper, 1961 1948-1951, and 1 in 4000 for 1951-1954 ; the report concluded that this frequency did not exceed the expected natural occurrence rate in the age groups under review-an assumption of dubious logicand dismissed as coincidental those occurring after 72 hours. Str0m (1960, 1967) investigated various encephalopathic complications (convulsions, 'shock', and meningism) occurring up to 7 days after inoculation in Swedish children and found 1 in 6000 in the period 1955-1958, and 1 in 3600 in 1950-1965 (Cockburn, 1951; Kong, 1953; Halpern and Halpern, 1955; Berg, 1958) .
A series of children believed to have reacted adversely to DPT inoculation has been studied retrospectively in an attempt to clarify these issues.
Patients
Between January 1961 and December 1972 approximately 50 children have been seen at The Hospital for Sick Children, London, because of neurological illness thought to be due to DPT inoculation. Several children with screaming and fever during the first 24 hours have been excluded from the study because of their benign outcome. The majority of the remainder, whose ages ranged from 3 months to 7 years were referred months or years after the acute episode, usually because of problems related to the sequelae, and are therefore a selected group. There were 36 children in whom there was adequate data on the timing, and only those neurological illnesses occurring up to 14 days after DPT inoculation were included.
Results
Sex distribution. There were 13 boys and 23 girls.
Age at immunization. Findings are shown in Table I , and reflect the Department of Health's recommendations. Interval and number of inoculations. The interval between inoculation and the occurrence of complications, together with the number of the provocative inoculations are shown in Table II . Among the patients presenting in the earlier years were those inoculated at three successive monthly intervals. Lately, only two injections were given at monthly intervals followed by a 'booster' DPT inoculation several months later. Sequelae. Two children (previously mentioned) died within 6 months of the onset of complications; in only one did inoculation seem directly contributory.
4B
Four children recovered completely. 22 were mentally retarded to a moderate or severe degree and also suffered from epilepsy, while severe but otherwise uncomplicated mental subnormality occurred in 4 children, and in 3 epilepsy was unaccompanied by mental retardation. One child with persistent hemiparesis developed normally otherwise.
Possible contributing factors. In 12 children there were factors operating which may have predisposed to the development of complications, and these are presented in Table IV . One child with possible birth injury had a difficult breech delivery and required intubation.
Of the coincident infections that were a feature in 5 children, upper respiratory tract infections had started 2 days before inoculation in 3 children (from one of whom cytomegalovirus was cultured). Chickenpox appeared 2 weeks before immunization in one child, and from the fifth child who became very ill within 24 hours of inoculation with diarrhoea and dehydration, Coxsackie group A type 7 virus was isolated. (Medical Research Council, 1956 ). We do not think, however, that the majority of cases we report here represent a chance association because of the clustering of illness in the 7 days after inoculation, and particularly in the first 24 hours (Table III) . This clustering is outstanding in the records of the Department of Neurology where there has been a sustained attempt to document both the date of onset of all neurological illness and also the timing of inoculations.
It is assumed that the pertussis component is responsible because the reactions described after DPT inoculation are similar to those seen after pertussis vaccine alone, and also after a natural infection. It is noteworthy that the reactions may occur after any of the inoculations in a series, but most commonly after the first or second. We did not have any evidence of more than one child seriously affected by material from the same ampoule of vaccine, and this has been the experience of others, suggesting an idiosyncratic response rather than a faulty batch.
We do not think that data from our study are of direct help for the debate on the merits of pertussis inoculation because we do not know either the prevalence of natural infection or the frequency of inoculation encephalopathy in the population we serve. We suggest, however, that in as many as a third of our patients there were contraindications to inoculation with pertussis vaccine, in that there was a previous history of fits, or family history of seizures in a first-degree relative; reaction to previous inoculation; recent intercurrent infection; or presumed neurodevelopmental defect.
These findings are contrary to the experience of certain authorities. For example, Illingworth (1965) has claimed that he has never seen a complication from DPT inoculation in a child who has had previous convulsions.
The differences between our two views may be due to differences in selection, and the conflict can only be resolved by a careful prospective study of the frequency and circumstances of possible complications. We recommend that pertussis vaccine is withheld from the groups of infants mentioned above, or administration postponed in those recently ill; this policy is unlikely to affect 'herd' immunity significantly.
Finally, we urge the systematic reporting of reactions to all forms of inoculation to the Committee on Safety of Medicines, since we understand that few, if any, reactions to DPT inoculation are notified to the Committee. 
